Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The oncogenic potential of YAP requires Y357 phosphorylation in cholangiocytes but not in hepatocytes

Cellular Oncology(2025)10.1007/s13402-025-01133-xSource: DataRank Database

The oncogenic potential of YAP requires Y357 phosphorylation in cholangiocytes but not in hepatocytes is a research paper published in Cellular Oncology (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

uniprot doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: goldTopics (36)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Jayla T. Millender,Chantal E. McCabe ORCID,Ryan D. Watkins,Jennifer A. Yonkus ORCID,EeeLN H. Buckarma ORCID

Live enrichment

PubMed:41442017 PMC:PMC12738621 OpenAlex:https://openalex.org/W7117116749

National Institutes of Health

Grant: R01 DK124182

Center for Cell Signaling in Gastroenterology, Mayo Clinic

Grant: P30DK084567

Cholangiocarcinoma Foundation

Fifth District Eagles Cancer Telethon

FWCI

0.00

Citation Percentile

0.5%

goldLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s13402-025-01133-x.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s13402-025-01133-x.pdf

publisherhttps://link.springer.com/article/10.1007/s13402-025-01133-x

journalhttps://doi.org/10.1007/s13402-025-01133-x

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41442017

Fields of Study

Hippo pathway signaling and YAP/TAZLiver physiology and pathologyProteoglycans and glycosaminoglycans research

MeSH Terms

YAP-Signaling ProteinsAnimalsCarcinoma, HepatocellularHumansLiver NeoplasmsMice, Inbred C57BLPhosphoproteinsPhosphorylationTranscription FactorsTyrosineSignal TransductionCholangiocarcinomaCell Cycle ProteinsHepatocytesCell Line, TumorAdaptor Proteins, Signal TransducingMiceCarcinogenesis

Keywords

PhosphorylationHippo signaling pathwayCarcinogenesisTransfectionPhenotypeTyrosine phosphorylationCell cultureSignal transductionCellHCCLineage CommitmentIccaYes-associated Protein (Yap)Chcc-ccaLiver Plasticity

Sustainable Development Goals

SDG 0: Good health and well-being

The oncogenic potential of YAP requires Y357 phosphorylation in cholangiocytes but not in hepatocytes

FAIR Checklist

Authors (12)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)